PenderFund Capital Management »

Lisata Therapeutics shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Lisata Therapeutics (LSTA) shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Lisata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lisata Therapeutics held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lisata Therapeutics by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $238k 48k 5.01

More positions owned by PenderFund Capital Management

First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Northern Oil & Gas Note 3.625% 4/1 (Principal)
Fluence Energy Note 2.250% 6/1 (Principal)
Southern Note 4.500% 6/1 (Principal)
Nio Note 4.625%10/1 (Principal)
Equinox Gold Corp Note 4.750%10/1 (Principal)
Abrdn Platinum Etf Trust Physcl Platm Shs (PPLT)
Duke Energy Corp Note 4.125% 4/1 (Principal)
Nio Note 3.875%10/1 (Principal)
Ppl Cap Fdg Note 2.875% 3/1 (Principal)
Evolent Health Note 3.500%12/0 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Teucrium Commodity Tr Corn Fd Shs (CORN)
Cardlytics Note 4.250% 4/0 (Principal)
Telesat Corp Cl A & Cl B Shs (TSAT)

View all positions for PenderFund Capital Management

Top funds holding Lisata Therapeutics

Vanguard Capital Management
Vanguard Group
Renaissance Technologies
Deltec Asset Management
Rangeley Capital
Geode Capital Management
CSS
BlackRock
PenderFund Capital Management
Vanguard Fiduciary Trust
Citadel Advisors
State Street Corporation
JBF Capital
HPM Partners
SOL Capital Management

View all funds holding Lisata Therapeutics